Multibagger stock: Balaxi Ventures nearly doubles in one month!
Balaxi Ventures has almost doubled in one month and is also, catching investors’ attention.
The stock is up by almost 500 per cent in one year. The company is engaged in the business of international wholesale distribution of pharmaceuticals formulations, builders’ hardware, and FMCG products. In FY20, the pharmaceuticals segment contributed 63 per cent of the company's revenue at Rs 28.71 crore. The FMCG segment contributed 32 per cent of the revenue of the company at Rs 14.52 crore. The builder's hardware segment contributed 5 per cent of the revenue of the company at Rs 2.40 crore.
One of the reasons why the stock is rallying is a strong financial trend. The company has declared outstanding results this quarter. The net sales increased by 156 per cent on a YoY basis while the operating profits improved by 339 per cent. The standalone net profits increased by 357 per cent while the operating profit margins stood at 9.47 per cent. The company has delivered good profit growth of 130.45 per cent CAGR over the last five years. The company has a good return on equity (ROE) track record showcasing 3 years ROE of 37.96 per cent. The company is virtually debt-free.
Promoters hold 72 per cent in the company while, FIIs hold 19 per cent. Non-institutional investors hold 8.11 per cent while other DIIs hold 0.03 per cent in the company. The market cap of the company is Rs 487 crore while the RoE (1 year) stands at 41.10 for Balaxi Ventures. The current P/E for the company stands at 47.89.